Use of N-acetylcysteine as treatment adjuvant regulates immune response in visceral leishmaniasis: Pilot clinical trial and in vitro experiments.
Magalhães LS, Melo EV, Damascena NP, Albuquerque ACB, Santos CNO, Rebouças MC, Bezerra MO, Louzada da Silva R, de Oliveira FA, Santos PL, da Silva JS, Lipscomb MW, da Silva ÂM, de Jesus AR, de Almeida RP.
Magalhães LS, et al. Among authors: de oliveira fa, de almeida rp, de jesus ar.
Front Cell Infect Microbiol. 2022 Nov 24;12:1045668. doi: 10.3389/fcimb.2022.1045668. eCollection 2022.
Front Cell Infect Microbiol. 2022.
PMID: 36506010
Free PMC article.
Clinical Trial.